| Oxford BioMedica and AGI Therapeutics Push On with Drugs That ... - Genetic Engineering News (press release) |
|
|
Genetic Engineering News (press release)The company also says that the FDA supports its goal of pushing on with development of the product in subsets of renal cancer patients and for other cancer ...Oxford Biomedica Announces Interim Results From Phase III TRIST ... read more |